The large conductance Ca 2+ -activated K + (BK) channels, abundantly expressed in coronary artery smooth muscle cells (SMCs), play a pivotal role in regulating coronary circulation. A large body of evidence indicates that coronary arterial BK channel function is diminished in both type 1 and type 2 diabetes. However, the consequence of coronary BK channel dysfunction in diabetes is not clear. We hypothesized that impaired coronary BK channel function exacerbates myocardial ischemia reperfusion (I/R) injury in streptozotocin (STZ)-induced diabetic mice.
Introduction
Diabetes mellitus has become an epidemic worldwide. The global prevalence of diabetes is estimated to be 9% among adults according to the World Health Organization global status report. Diabetes is associated with a 2-to 4-fold increase in the risks of cardiovascular diseases which remain the leading cause of death in both men and women with diabetes (Snell-Bergeon & Wadwa, 2012) . A large body of clinical evidence has shown that the poor prognosis of acute myocardial infarction and cardiac sudden death in patients diagnosed with diabetes is attributed to compromised coronary blood flow and increased susceptibility of myocardial ischemia (Kurisu et al., 2003; Cubbon et al., 2007; Yeung et al., 2012) . Despite advances in the management of diabetes, the cardiovascular morbidity and mortality in diabetic patients remain twice that of non-diabetic patients (Wackers, 2005; Norhammar et al., 2007) . However, the molecular mechanisms that underlie the poor cardiovascular outcome in diabetic patients are not fully understood.
Because of high unitary conductance and high density in coronary smooth muscle cells (SMCs), the large conductance Ca 2+ -activated K + (BK) channels play a negative feedback role in the regulation of vascular tone and cardiac perfusion. Activation of vascular BK channels by elevated intracellular free Ca 2+ concentrations gives rise to the generation of spontaneous transient outward currents that hyperpolarize the membrane potentials, shut off the voltagedependent Ca 2+ channels in vascular SMCs and lead to vascular relaxation (Nelson et al., 1995; Jaggar et al., 1998) . Functional vascular BK channels are octameric complexes with four poreforming α subunits (BK-α, encoded by Slo1 gene) and four regulatory β1 or γ1 subunits (BK-β1
or BK-γ1) (Tanaka et al., 1997; Evanson et al., 2014) . In diabetes, however, the BK channel D r a f t 4 function is diminished in many vascular beds including those of coronary arteries (Lu et al., 2010; Zhang et al., 2010; Wang et al., 2012; Yi et al., 2014) . Whether coronary BK channel dysfunction contributes to worsened outcome of cardiovascular diseases with diabetes has not been studied.
Caveolae are flask-shaped nonclathrin-coated plasma membrane structures that contain the signature protein, caveolin (Cav). Three Cav isoforms are known: Cav-1, Cav-2 and Cav-3. Cav-1 and Cav-2 are present in vascular endothelial cells and SMCs, while Cav-3 is primarily expressed in cardiac and skeletal muscles (Krajewska & Maslowska, 2004) . The N-terminus of Cav-1 contains an important functional structure: the Cav scaffolding domain, which is essential for interaction with other proteins containing the Cav binding motifs (ΦXΦXXXXΦ or ΦXXXXΦXXΦ, where Φ represents an aromatic amino acid and X is any amino acid) (Krajewska & Maslowska, 2004) . Such Cav binding motifs are present in human BK-α (1102-YNMLCFGIY-1110) and human AT1R (304-FLGKKFKRY-312), but not in human BK-β1 or BK-γ1. Caveolae are membrane microdomains that assemble signaling molecules including those of Ang II (Ushio-Fukai & Alexander, 2006) . Two types of Ang II receptors are expressed in the heart: type 1 (AT1R) and type 2 (AT2R) with AT1R being the dominant isoform that mediates the major cardiovascular effects of Ang II (Dasgupta & Zhang, 2011) . We have demonstrated that Ang II promoted in AT1R trafficking into the caveolae of vascular SMCs, forming the BK channel-AT1R-caveolae microdomain complexes. Importantly, such caveolae compartmentation was enriched in diabetic vessels, potentiating the inhibitory effect of Ang II on BK channels in the vicinity and promoting coronary vasoconstriction (Lu et al., 2010) . In addition, it has been reported that caveolae facilitated direct coupling between BK channels and D r a f t 5 L-type Ca 2+ channels in vascular SMCs to regulate vascular tone (Suzuki et al., 2013) . However, the role of BK channel-AT1R-caveolae microdomain complexes in cardiovascular diseases, particularly with diabetes, has not been established. In this study, we found that dysregulation of coronary smooth muscle BK channel activity contributes to exacerbated ischemia/reperfusion (I/R) injury in diabetic mouse hearts, due to an increase of BK chanel-AT1R-caveolae microdomain compartmentation in coronary SMCs. Activation of coronary BK channels and suppression of AT1R-caveolae signaling minimized myocardial I/R injury in diabetic mice.
Hence, protection of coronary BK channel function may serve as a novel molecular target for the treatment of cardiovascular complications in diabetes.
Materials and methods

Diabetic mouse model
/J) and wild type (wt) control mice (C57BL/6J) were purchased from the Jackson Laboratory at 4 weeks of age. Mice received a STZ injection (100 mg/kg body weight, ip.) and those with blood glucose higher than 300 mg/dl were considered diabetic. Eight weeks after developing hyperglycemia, mice and agematched controls were sacrificed and used for experiments. All animal protocols were approved by the Mayo Clinic Institute Animal Care and Use Committee (Rochester, MN).
Coronary SMC isolation and BK channel current recording  Mouse coronary SMCs were enzymatically isolated for whole-cell K + current recordings as we have previously described (Lu et al., 2010; Lu et al., 2012 Sucrose gradient density centrifugation  The cellular distributions of caveolae-targeted BK channels and AT1R in mouse aortic SMCs were determined by sucrose density gradient fractionation as previously described (Wang et al., 2005; Lu et al., 2010) . Cells were homogenized in 500 mM Na 2 CO 3 with 2% protease inhibitors (v/v), and then centrifuged at 5,000 rpm at 4 °C for 10 min. One ml of the supernatant were adjusted to 40% sucrose-MBS (2-
[N-morpholino]-ethanesµfonic acid) by adding 1 ml of 80% sucrose-MBS, placed to the bottom of a 6-ml ultracentrifuge tube, layered with a 2-ml discontinuous sucrose gradient (40%, 30%
and 5%), and centrifuged at 32,000 rpm at 4 °C for 20 h. Eight fractions of 1.25 ml each were collected and analyzed by immunoblotting.
Co-immunoprecipitation (Co-IP) and immunoblotting  Co-IP and immunoblotting were performed as we have previously reported (Lu et al., 2010; Lu et al., 2012) . Mouse aortas were incubated with 200 µl RIPA buffer (in mM): Tris 50, NaCl 150, NaF 2 1, EDTA 1, EGTA 1, NaVO 4 1, and 1% Triton X-100 (pH 7.5) and 1 µl protease inhibitor on ice for 30 min, homogenized and then centrifuged at 2000 rpm at 4 °C for 10 min. Lu et al., 2010; Zhang et al., 2010; Yi et al., 2014) .
Optical density of the bands was analyzed using Scion Image software (Scion Corp.). Invitrogen Co., catalog number 36934). Cells were visualized using a confocal laser microscope (LSM 510, Zeiss) with a 60X water immersion lens (Wang et al., 2005; Lu et al., 2010) .
Confocal immunofluorescence microscopy
Quantitative correlation of the fluorescence intensities of two images was analyzed using ImageJ JaCop (Bolte & Cordelieres, 2006; Schneider et al., 2012 end of reperfusion as previously described (Gelpi et al., 2002) . The ischemia-reperfusion protocols (Gelpi et al., 2002) for isolated hearts were conducted as follows: (i At the end of the I/R procedure, the heart was perfused with 1% 2,3,5-triphenyltetrazolium chloride (TTC) in 0.1 M phosphate buffer (pH 7.4) at 37 °C for 10 min (Gao et al., 2002) . Viable myocardium containing dehydrogenase enzymes was stained brick red by reacting with TTC, whereas infarct tissue remained unstained (white color) because of the lack of the enzymes. After D r a f t incubation overnight with 10% formaldehyde, the heart was cut into 6 to 8 slices (each 0.1 mm thick) and the infarct weight was calculated as:
A1W1+A2W2+··· ···+A7W7+A8W8, where A is the area of infarct as a percentage of the total area of the slice and W is the weight of the respective section. TTC-stained area and TTC negative area were measured digitally using ImageJ software (Schneider et al., 2012) . The cardiac infarct size (ΣAW) was presented as a percentage of the total weight of the heart.
In vivo myocardial I/R studies  The surgical in vivo ischemia-reperfusion procedure was performed as previously described (Suzuki et al., 2002) . Mice were anesthetized with pentobarbital (60 mg/kg, ip.) and anesthesia was maintained by 1.5% isoflurane with O 2 through a vaporizer (Midmark Co.). Anesthetized mice were placed on a heating plate (at 37 °C) to keep the body temperature stable. Mice were tracheotomized, intubated, and ventilated with a small animal ventilator (Kent Scientific Co.). The tidal volume and ventilation rate were 0.5 to 0.6 ml and 100 to 120 strokes per min, respectively. Thoracotomy was performed through the third left intercostal space, and the pericardium was opened. A 7-0 silk suture was passed around the left anterior descending coronary artery (LAD) using a tapered needle. Electrocardiogram (ECG) limb leads were placed on the fore-and hind-limbs to record cardiac ECG throughout the experiment. A balloon catheter was inserted into the femoral artery to monitor systemic blood pressure. Acute myocardial ischemia was induced by ligation of the LAD for 40 min, followed by a 60-min of reperfusion achieved by releasing the ligation. After reperfusion, the heart was rapidly excised and mounted on the cannulus connected to a syringe. 1% TTC (10 ml, at 37 °C)
was injected into the coronaries retrogradely through the aorta. Then, the heart was cut into 6 to 8 transverse slices for infarct size measurements. (Fig. 2) , suggesting that the NS1619 effects on cardiac infarct size is more complicated than our original thoughts.
In non-diabetic Cav-1 -/-mouse hearts, the infarct size (28.8±2.4%, n=7) induced by I/R procedure was about half that of non-diabetic wt controls (p=5.6x10 -4 ). Pretreatment and reperfusion with 2 µM Ang II produced significantly larger infarcts (46.7±3.6%, n=7, p=0.003 vs non-diabetic Cav-1 -/-controls), similar to those of non-diabetic wt mice without treatment. IBTX pretreatment also greatly augmented the infarct size (84.9±3.9%, n=7, p=2.2x10 -7 vs non-diabetic
Cav-1 -/-controls), which was twice that of Ang II-treated Cav-1 -/-mice (p=1.0x10 -4 ) and comparable to that of non-diabetic wt with IBTX treatment (p=0.23) (Fig. 3) . It is worth noting that the effect of IBTX on I/R-induced myocardial infarction was independent of Cav-1 D r a f t 13 expression in coronary SMCs, suggesting that AT1R-caveolae signaling is the upstream of coronary BK channel modulation. Furthermore, the presence of diabetes significantly enlarged I/R-induced myocardial infarct size in Cav-1 -/-mice (44.7±6.0%, n=9, p=0.040 vs non-diabetic
Cav-1 -/-controls), but it was smaller than that of diabetic wt mice (p=5.8x10 -4 ) and IBTX-treated non-diabetic Cav-1 -/-mice (p=2.9x10 -4 ) (Fig. 3) . In addition, pretreatment with 10 µM NS1619 significantly minimized myocardial infarct size in diabetic Cav-1 -/-mice to 23.6±5.4% (n=7, p=0.023 vs diabetic Cav-1 -/-mice), similar to that of non-diabetic Cav-1 -/-mice without treatment (Fig. 3) . The changes in LVDP of wt and Cav-1 -/-mice before and after I/R procedure are summarized in Table 1 . Note: γ is from 1 to -1, with 1 standing for complete positive correlation and -1 for negative D r a f t correlation, with 0 standing for no correlation). In addition, co-IP studies detected both BK-α and AT1R in the immunoprecipitates pulled down by anti-Cav-1 antibody from the cell lysates of mouse aortas, suggesting there was physical interaction of Cav-1, BK-α and AT1R. Moreover, the colocalization of BK-α and AT1R in caveolae microdomain complexes was enriched in diabetic mouse vessels, compared to that of non-diabetic controls (Fig. 4C) .
Colocalization of BK-α and AT1R in the caveolae of coronary SMCs of mice
Cav binding motif of AT1R is essential for Ang II-mediated BK channel inhibition     We have
reported that pretreatment of Ang II facilitated AT1R trafficking into the caveolae of aortic SMCs of rats and enhance its effect on BK channel inhibition, and ablation of Cav-1 preserved BK channel activity in diabetic vessels (Lu et al., 2010) . To further delineate the molecular mechanism underlying BK channel dysregulation by caveolae-targeting, we generated an AT1R mutation in the Cav binding motif by substituting the phenylalanine residue at 309 with an alanine (AT1R F309A) and examined the effects of Ang II on hSlo-HEK293 cell line 48 h after co-transfection of Cav-1 wt cDNAs with AT1R wt or the AT1R F309A mutant. Fig. 5A shows the time course of hSlo currents recorded at +100 mV in hSlo-HEK293 cell line transiently cotransfected with Cav-1 wt and AT1R wt cDNAs after exposure to Ang II (2 µM), Losartan (10 µM) and IBTX (0.1 µM). Ang II suppressed about 40% of hSlo currents and the Ang II effect was reversible upon washing out and blocked by Losartan (Fig. 5B ). Ang II had no effect on hSlo currents stably expressed in HEK293 cells after co-transfection with AT1R F309A and Cav-1 wt cDNAs, while BK channel expression remained intact as shown by sensitivity to IBTX (Fig. 6A ). 
Discussion
The clinical outcome of patients with acute coronary events is dependent on the maintenance of effective myocardial perfusion (Wackers, 2005; Esposito et al., 2014) . Studies over the last couple of decades improved our understanding on the pathological mechanisms of myocardial I/R injury which involve myocardial factors and vascular factors (Yellon & Hausenloy, 2007) .
The vascular factors are attributed to microvessel obstruction and blood flow deficiency in previously ischemic region of the heart after coronary angioplasty, contributing to the "noreflow" phenomenon (Hoffmann et al., 2003) . It is well known that pathological and functional changes in diabetic coronary endothelium contribute to exacerbated I/R-induced myocardial injury, including increased platelet activation and clot coagulation, as well as aggravated inflammatory response (Hausenloy & Yellon, 2013) . In this study, we have further demonstrated that coronary smooth muscle BK channel activity is also important for the I/R-induced myocardial infarction, particularly in diabetic hearts. Activation of AT1R by Ang II and suppression of BK channels by IBTX enlarged myocardial infarct size in non-diabetic mice, similar to the effects of diabetes. Blockade of AT1R by Losartan and activation of BK channel by NS1619 reduced Ang II-induced myocardial infarct size and improved cardiac contractility.
More importantly, the infarct size in diabetic hearts was reduced by NS1619 to a level even smaller than that in diabetic controls and in Ang II-treated mice, suggesting coronary BK channel dysfunction may play a fundamental role in the outcome of myocardial I/R injury, particularly in diabetes. It has been reported that NS1619 protects the heart by activating D r a f t 16 myocardial mitochondrial BK channels (Singh et al., 2013) , cardiac neuron BK channels (Wojtovich et al., 2013) and other non-selective ion channels (Cancherini et al., 2007) . Indeed, activation of mitochondrial BK channels has protective effects on cardiac I/R injury (Sakamoto et al., 2008; Borchert et al., 2011; Singh et al., 2013; Testai et al., 2013) . We believe that activation of sarcolemma BK channels in coronary SMCs is also critical in reducing I/R-induced myocardial infarct size in diabetic mice, based on following reasons: First, the effects of NS1619 on cardiac protection were abolished by IBTX which is membrane impermeable, indicating the involvement of sarcolemmal BK channels rather than mitochondrial BK channels. It is worth noting that BK channels are not found in the sarcolemma of cardiac myocytes (Singh et al., 2012) and are poorly expressed in the most freshly isolated vascular endothelial cells (Feletou, 2009 ). Second, significant reduction in myocardial infarct size was associated with ablation of the Cav-1 gene that is expressed in the vasculature, but not in myocardium which expresses Cav-3. A recent study also showed that forskolin-induced myocardial infarct size reduction was blocked by IBTX, demonstrating the protective role of vascular BK channels in whole heart I/R injury (Heinen et al., 2014) .
The molecular mechanisms underlying BK channel regulation by caveolae-targeting could be complicated. It has been reported that inhibition of BK channel activity by Ang II is mediated through posttranslational modification of BK-α protein (Lu et al., 2010) or a direct interaction between AT1R and BK-α proteins (Zhang et al., 2014) . In addition, binding of BK-α to Cav scaffolding domain results in a decrease of BK channel current density in cultured endothelial cells (Wang et al., 2005; Riddle et al., 2011) . Interestingly, we found that there is an increase of colocalization of BK-α and AT1R, but not BK-β1, in the caveolae of diabetic vascular SMCs.
D r a f t
Such cellular distribution of protein profiles will greatly suppress BK-α activity not only through proximity with AT1R and its downstream signaling, but also through a physical dissociation with BK-β1. This contention is supported by the finding that with the loss of caveolae integrity, coronary BK channel activity is preserved and I/R-induced myocardial infarct size in diabetic mice is attenuated.
Ang II plays an essential role in the regulation of cardiovascular homeostasis. AT1R and its associated signaling proteins, such as G-proteins, non-phagocytic NAD(P)H oxidases (NOXs) and c-Src kinase, are colocalized in the caveolae of vascular SMCs (Ushio-Fukai & Alexander, 2006; Lu et al., 2010) . Upon stimulation by Ang II, AT1R translocates into the caveolae, activates protein kinase C and NOXs, promotes reactive oxygen species (ROS) generation (Touyz & Schiffrin, 2000) and leads to the redox-mediated protein modification of BK channels (Lu et al., 2010) . It is known that development of diabetic vascular dysfunction is associated with augmented Ang II signaling and increased ROS production (Van Linthout et al., 2008; Giacco & Brownlee, 2010) . However, the roles of the renin-angiotensin system in cardiac I/R injury remain controversial. Autoradiography and immunohistochemistry experiments found that AT1R expression in the infarct area of rats was upregulated after myocardial I/R (Higuchi et al., 2010) . AT1R antagonists preserved cardiac function against I/R injury (Flynn & Akers, 2003; Han et al., 2013) . In contrast, some studies suggested that Ang II had protective effects on cardiac I/R injury through Ang II initiated myocardial preconditioning as a result of increase in mitochondrial ROS generation with activation of JNK and p38 MAP kinase pathways (Kimura et al., 2005; Das et al., 2006) . Reasons for the discrepancy among these studies are unclear, but they may reflect the differences in the animal species used and experimental conditions employed. In particular, the range of Ang II concentration for vasoconstriction studies was D r a f t varied from 10 -12 to 10 -4 M and the efficiency of Ang II was vascular bed dependent (Pallone, 1994; Batenburg et al., 2004; Patzak et al., 2005; Park et al., 2012) . Since there was a 10-fold increase of Ang II production in cardiomyocytes of STZ-induced diabetic rats (Singh et al., 2008) , we applied Ang II in 10 -6 M range to Langendorff-perfused hearts to mimic a gain of activity of renin-angiotensin in diabetic hearts as we have published (Lu et al., 2010) . We found that the worsening of I/R-induced myocardial injury by Ang II was caveolae-dependent and mediated through the inhibition of coronary BK channel function. In Cav-1 -/-hearts, the I/Rinduced myocardial infarct size produced by Ang II was about 40% smaller than that in wt mice, suggesting the role of caveolae in mediating the detrimental effects of Ang II. However, the effect of IBTX on I/R-induced myocardial infraction was similar between Cav-1 -/-and wt mice, indicating that coronary BK channels are the downstream of AT1R signaling.
Our study has potential limitations. First, cardiovascular complications are commonly associated with type 2 diabetes mellitus. However, STZ injection usually induces type 1 diabetes rather than type 2 diabetes. Use of high fat-diet or genetic induced type 2 diabetic mouse models will have a better clinical relevant. Second, the maximal efficacy of Ang II is about in 10 -7~1 0 -8 M range. We applied a relative high Ang II concentration to isolated perfusion hearts to mimic an increase of Ang II production in diabetes, although we did not measure serum Ang II level in STZ diabetic mice. However, we have shown deleterious roles of caveolae and diabetes in myocardial I/R study in vivo, similar to the results observed from ex vivo study. Hence, we believe that conclusions derived from these experiments are valid.
In summary, our study demonstrated a novel mechanism by which the receptor-channel- 
